Compounds > phorbol 12,13-dibutyrate
Page last updated: 2024-08-23

phorbol 12,13-dibutyrate and Acute Disease

phorbol 12,13-dibutyrate has been researched along with Acute Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukuuchi, Y; Gomi, S; Mihara, B; Takashima, S; Tanaka, K1
Didion, SP; Mayhan, WG1

Other Studies

2 other study(ies) available for phorbol 12,13-dibutyrate and Acute Disease

ArticleYear
Enhanced maximal binding capacity (Bmax) of second messenger ligand in the acute phase of cerebral ischemia--direct visualization by digital image analysis.
    Neuroscience research, 1994, Volume: 19, Issue:4

    Topics: Acute Disease; Animals; Autoradiography; Brain Ischemia; Cerebrovascular Circulation; Colforsin; Female; Gerbillinae; Image Processing, Computer-Assisted; Ligands; Male; Phorbol 12,13-Dibutyrate; Second Messenger Systems

1994
Activation of protein kinase C does not participate in disruption of the blood-brain barrier to albumin during acute hypertension.
    Brain research, 1995, Oct-23, Volume: 696, Issue:1-2

    Topics: Acute Disease; Animals; Blood Pressure; Blood-Brain Barrier; Capillary Permeability; Enzyme Activation; Enzyme Inhibitors; Hypertension; Male; Naphthalenes; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rats; Rats, Sprague-Dawley; Sphingosine

1995